T10385	SO:0001026 38072 38079	genomic
T10386	SO:0000153 38136 38139	BAC
T10387	SO:0001026 38140 38147	genomic
T10388	SO:0000345 38175 38178	EST
T10389	SO:0001434 38213 38215	to
T10390	SO:1000065 38282 38295	fragmentation
T10391	SO:0000313 38296 38299	and
T10392	SO:0000153 38343 38348	based
T10393	SO:0000205 38392 38395	the
T10394	SO:0001870 38396 38400	ERK5
T10395	SO:0000204 38433 38438	first
T10396	SO:0001434 38486 38487	I
T10397	SO:0001434 38488 38489	/
T10398	SO:0001111 38517 38518	a
T10399	SO:0000694 38846 38851	using
T10400	SO:0000403 38932 38937	grown
T10401	SO:0001846 39002 39013	fibroblasts
T10402	SO:0000121 39014 39018	from
T10403	SO:0001111 39035 39036	a
T10404	SO:0000313 39083 39086	and
T10405	SO:0001870 39159 39163	ERK5
T10406	SO:0001867 39164 39173	targeting
T10407	SO:0001867 39206 39215	targeting
T10408	SO:0001900 39288 39310	GGCCCAATGGAAAGGCTTCTAT
T10409	SO:0001088 39310 39311	.
T10410	SO:0001088 39335 39341	screen
T10411	SO:0000345 39391 39393	ES
T10412	SO:0001157 39394 39398	cell
T10413	SO:0000188 39443 39447	into
T10414	SO:0000156 39484 39489	cross
T10415	SO:0001434 39489 39490	,
T10416	SO:0001061 39524 39533	recipient
T10417	SO:0001031 39586 39590	bred
T10418	SO:0000700 39620 39629	indicated
T10419	SO:0000313 39630 39633	and
T10420	SO:0001467 39675 39677	of
T10421	SO:0001337 39767 39771	mice
T10422	SO:0000205 39839 39842	the
T10423	SO:0000313 39959 39962	and
T10424	SO:0001904 39963 39987	ACCACCAAGCGAAACATCGCATCG
T10425	SO:0001030 40050 40056	female
T10426	SO:0001847 40113 40126	fertilisation
T10427	SO:0001529 40127 40137	determined
T10428	SO:0001434 40172 40173	,
T10429	SO:0001030 40249 40256	females
T10430	SO:0000313 40309 40312	and
T10431	SO:0001366 40313 40317	used
T10432	SO:0000006 40345 40348	PCR
T10433	SO:0001434 40384 40385	,
T10434	SO:0001434 40463 40464	4
T10435	SO:0001080 40464 40465	%
T10436	SO:0000296 40518 40521	out
T10437	SO:0001434 40583 40585	to
T10438	SO:0000205 40630 40633	the
T10439	SO:0001434 40634 40635	3
T10440	SO:0001434 40651 40652	(
T10441	SO:0000006 40879 40891	PCR products
T10442	SO:0000077 40929 40938	antisense
T10443	SO:0000167 40977 40985	promoter
T10444	SO:0001462 40988 40999	Whole mount
T10445	SO:0001493 41048 41052	CD31
T10446	SO:0001462 41081 41092	Whole mount
T10447	SO:0000313 41144 41147	end
T10448	SO:0000296 41178 41181	out
T10449	SO:0000207 41238 41257	Sectioning Embryos
T10450	SO:0000205 41295 41299	then
T10451	SO:0000313 41334 41344	chloroform
T10452	SO:0000643 41394 41407	Sections were
T10453	SO:0000147 41447 41452	eosin
T10454	SO:0000719 41455 41465	The atrial
T10455	SO:0001404 41504 41512	modified
T10456	SO:0000099 41536 41544	Both the
T10457	SO:0001353 41574 41580	atrial
T10458	SO:0001134 41619 41623	wall
T10459	SO:0001030 41743 41752	Between 6
T10460	SO:0002163 41786 41792	embryo
T10461	SO:0001434 41814 41815	4
T10462	SO:0001226 41848 41870	Immunoblotting Tissue
T10463	SO:0001036 41900 41901	-
T10464	SO:000440 41913 41914	1
T10465	SO:0001642 42132 42150	Insoluble material
T10466	SO:0000771 42190 42191	g
T10467	SO:0001434 42207 42208	C
T10468	SO:0000205 42210 42224	Soluble lysate
T10469	SO:0001434 42242 42245	run
T10470	SO:0001026 42270 42274	gels
T10471	SO:0000144 42342 42360	Primary antibodies
T10472	SO:0000313 42381 42384	and
T10473	SO:0000205 42416 42419	the
T10474	SO:0001429 42475 42495	Secondary antibodies
T10475	SO:0000050 42543 42549	Pierce
T10476	SO:0001318 42585 42588	ECL
T10477	SO:0001605 42603 42624	Authors contributions
T10478	SO:0001467 42657 42659	of
T10479	SO:0001300 42695 42699	most
T10480	SO:0001012 42726 42732	JC was
T10481	SO:0001357 42778 42783	mouse
T10482	SO:0001467 42821 42823	of
T10483	SO:0000515 42958 42966	JSCA was
T10484	SO:0001239 43001 43006	study
T10485	SO:0000983 43032 43052	Acknowledgements We
T10486	SO:0001830 43086 43089	for
T10487	SO:0001467 43136 43138	of
T10488	SO:0000346 43155 43163	We would
T10489	SO:0001830 43197 43200	for
